Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole/trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA.

Tacieli Fagundes da Rosa,Catrine de Souza Machado,Marissa Bolson Serafin,Angelita Bottega,Silvana Silveira Coelho,Vitória Segabinazzi Foletto,Roberta Filipini Rampelotto,Vinícius Victor Lorenzoni,Amanda Mainardi,Rosmari Hörner

Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole/trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA.

2021

Tacieli Fagundes da Rosa
Catrine de Souza Machado
Marissa Bolson Serafin
Angelita Bottega
Silvana Silveira Coelho
Vitória Segabinazzi Foletto
Roberta Filipini Rampelotto
Vinícius Victor Lorenzoni
Amanda Mainardi
Rosmari Hörner

Bacterial resistance has propelled one of the most serious public health problems in the world. In this sense, drug repurposing has emerged for faster identification of effective drugs. The aim of ...

Keywords:

Antibiotic resistance
Sulfamethoxazole/Trimethoprim
Multiple drug resistance
Minimum inhibitory concentration
Pharmacology
Escitalopram Oxalate
Chemistry
Minimum bactericidal concentration
Antibiotics
Ciprofloxacin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations